Astrid Otten Carranza
Psychiatry · Watertown, NYNPI 1902345192
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 309 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 309 payments — averaging $18.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$853
- Alkermes, Inc.$676
- Otsuka America Pharmaceutical, Inc.$505
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$453
- Takeda Pharmaceuticals U.S.A., Inc.$259
- plus $2K from 22 others
What the payments were for
- Food & beverage$5,53799%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 68 | $1,217 |
| Johnson & Johnson(2 entities) | 43 | $853 |
| Alkermes, Inc. | 43 | $676 |
| Otsuka America Pharmaceutical, Inc. | 27 | $505 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $453 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $259 |
| Teva Pharmaceuticals USA, Inc. | 17 | $242 |
| Vanda Pharmaceuticals Inc. | 11 | $201 |
| Daiichi Sankyo Inc. | 9 | $165 |
| Sunovion Pharmaceuticals Inc. | 10 | $155 |
| Neurocrine Biosciences, Inc. | 9 | $134 |
| Axsome Therapeutics, Inc. | 7 | $123 |
| Exact Sciences | 7 | $109 |
| Novo Nordisk | 5 | $108 |
| Lundbeck LLC | 4 | $65 |
| Dexcom, Inc. | 2 | $56 |
| Eisai Inc. | 2 | $35 |
| E.r. Squibb & Sons, L.L.C. | 2 | $35 |
| Hologic Sales And Service, LLC | 1 | $25 |
| Corium, LLC | 1 | $24 |
| Alk-abello, Inc | 1 | $21 |
| Kyowa Kirin, Inc. | 1 | $21 |
| Almatica Pharma LLC | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Pfizer | 1 | $17 |
| Amgen | 1 | $16 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,584 in reported general payments places this provider in the 90th percentile of 3,713 psychiatry providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 12 | $101,571 |
| VraylarCariprazine Hcl | 54 | $82,344 |
| SpravatoEsketamine Hcl | 25 | $47,414 |
| Invega SustennaPaliperidone Palmitate | 15 | $29,501 |
| Lurasidone Hcl | 28 | $15,108 |
| Aripiprazole | 178 | $9,862 |
| Atomoxetine Hcl | 26 | $3,338 |
| Methylphenidate ErMethylphenidate Hcl | 17 | $2,902 |
| Quetiapine Fumarate | 146 | $2,449 |
| Duloxetine Hcl | 92 | $2,208 |
| Olanzapine | 60 | $1,646 |
| Gabapentin | 133 | $1,422 |
| Divalproex Sodium ErDivalproex Sodium | 26 | $1,263 |
| Carbamazepine ErCarbamazepine | 14 | $1,217 |
| Bupropion Hcl | 75 | $1,155 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $134 | $101,57112 claims |
| AbbVieVraylar | $1,217 | $82,34454 claims |
| Johnson & JohnsonSpravato, Invega Sustenna | $853 | $76,91540 claims |
| Almatica Pharma LLCSertraline Hcl | $20 | $707235 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,713 psychiatry providers in New York.
Other psychiatry in Watertown
- Leslie CitromePomona$5.7M
- Sanjay GuptaCheektowaga$1.9M
- Richard PriceMonsey$1.7M
- Adam AshtonAmherst$1.6M
- Christoph CorrellGlen Oaks$1.5M
- Manish ZinzuvadiaNew York$1.3M
- George KruseBronx$1.2M
- Jianping ChenNew York$1.2M
- Horacio CapoteAmherst$1.1M
- Yadagiri ChepuruYonkers$963K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.